Sono-Tek Reports Strong Fiscal 2026 Results: Net Income Up 42%, Operating Income Up 81%, Cash Increases to $14.8M
SOTK sits 67% above its 52-week low of $3.23 on elevated volume (1.9× avg).
Summary
Sono-Tek Corp. reported robust fiscal year 2026 financial results, including a 42% increase in net income and an 81% surge in operating income, alongside a stronger cash position and no debt. New tax legislation (OBBBA) positively impacted R&D expensing, though the company noted a decline in Alternative/Clean Energy sales and customer concentration risk.
Key Events · Earnings and Guidance · SOTK
-
Strong Fiscal Year 2026 Financial Performance
Net sales increased 2% to a record $20.9 million, gross profit rose 8% to $10.6 million (51% margin), operating income surged 81% to $1.82 million, and net income grew 42% to $1.8 million, with basic and diluted EPS at $0.11.
-
Increased Cash and Backlog
Cash, cash equivalents, and marketable securities totaled $14.8 million, up from $11.9 million in the prior year. Equipment and service-related backlog reached an historically high fiscal year-end level of $9.12 million.
-
Impact of New Tax Legislation (OBBBA)
The 'One Big Beautiful Bill Act' (OBBBA), signed July 4, 2025, permanently restores 100% bonus depreciation and reinstates immediate expensing of domestic R&D costs, retroactively for 2022-2024 for small businesses, impacting deferred tax assets.
-
Mixed Market Performance and Customer Concentration
Medical market sales increased 54% and Electronics/Microelectronics sales rose 16%. However, Alternative/Clean Energy sales decreased 19% due to reduced electrolysis-related demand. One customer accounted for 28% of total revenues in fiscal 2026.
Analysis · SOTK · Technology
Sono-Tek Corp. delivered a strong financial performance for fiscal year 2026, with significant increases in net income and operating income. The company's cash position also improved substantially, and it maintains no outstanding debt, providing financial flexibility. A key development is the impact of the 'One Big Beautiful Bill Act' (OBBBA), which allows for immediate expensing of R&D costs, positively affecting deferred tax assets. While the company showed strong growth in Medical and Electronics/Microelectronics markets, it experienced a decline in Alternative/Clean Energy sales due to government policy changes. The filing also highlights a notable customer concentration, with one customer accounting for 28% of revenues.
At the time of this filing, SOTK was trading at $5.40 on NASDAQ in the Technology sector, with a market capitalization of approximately $83.4M. The 52-week trading range was $3.23 to $5.70. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.